These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9324582)
1. [Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]. Rozman C; Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Marín P; Bladé J; Cervantes F; López-Guillermo A; Nomdedeu B; Rozman M; Aguilar JL; Vives-Corrons JL; Mazzara R; Ordinas A; Ribera JM; Feliu E; Castillo R; Grañena A; Montserrat E Med Clin (Barc); 1997 May; 108(18):681-6. PubMed ID: 9324582 [TBL] [Abstract][Full Text] [Related]
2. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172 [TBL] [Abstract][Full Text] [Related]
4. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases]. Gratwohl A Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266 [TBL] [Abstract][Full Text] [Related]
5. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [TBL] [Abstract][Full Text] [Related]
7. Post-transplant infections: single center experience from the developing world. Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999 [TBL] [Abstract][Full Text] [Related]
8. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Gratwohl A; Passweg J; Baldomero H; Hermans J Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992 [TBL] [Abstract][Full Text] [Related]
9. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054 [TBL] [Abstract][Full Text] [Related]
11. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft. di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375 [TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
13. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]
14. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation. Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976 [TBL] [Abstract][Full Text] [Related]
15. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology. Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995 [TBL] [Abstract][Full Text] [Related]
16. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Pession A; Rondelli R; Paolucci P; Pastore G; Dini G; Bonetti F; Madon E; Mandelli F; Zanesco L; Uderzo C; Prete A; Rabusin M; Ugazio A; Di Bartolomeo P; Favre C; Bojd-Faulkner L; Poggi V; Luksch R; Donfrancesco A; Argiolu F; La Nasa G; Amici A; Locatelli F Haematologica; 2000 Jun; 85(6):638-46. PubMed ID: 10870122 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337 [TBL] [Abstract][Full Text] [Related]
20. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J Bone Marrow Transplant; 1998 Jul; 22(1):73-8. PubMed ID: 9678799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]